Company Atlas · Connected health technology
Withings: connected health devices under review
Withings combines consumer connected-health devices with professional health solutions. Independent studies support some device-specific measurements under bounded conditions, while also showing that accuracy varies by activity, model and intended use.
Company and operating model
Withings describes a connected-health ecosystem built around smart scales, hybrid watches, blood-pressure monitors, sleep devices, software and professional health solutions. Its public history says the company began in 2008, was acquired by Nokia in 2016 and returned to the Withings name after Eric Carreel reacquired it in 2018. Those facts describe the company's own account; they do not establish the accuracy or clinical value of every device, metric or service. The exact legal seller can vary by territory and must be checked at transaction level.
What independent device studies add
A 2022 free-living validation study compared ScanWatch heart-rate readings with a Polar H10 in seven adults over 12 hours. It reported an overall mean absolute percentage error of 5.1%, but accuracy weakened in some ambulatory activities and the authors did not consider the device suitable where clinical or trial-grade precision is required. A separate 2020 study of the older Activite model found systematic undercounting of absolute steps despite correlation with comparison monitors. These findings are model-, metric- and context-specific; they cannot validate the whole Withings portfolio.
Measurement is not diagnosis
Connected devices can make patterns visible, but a displayed value is not automatically a diagnosis, treatment recommendation or proof of improved health. Firmware, sensor placement, motion, skin characteristics, user behaviour, algorithms and reference methods can alter performance. A result for heart rate cannot be transferred to oxygen saturation, electrocardiography, sleep staging, body composition or blood pressure. Product pages and regulatory labels must therefore be read separately from independent validation and from real-world clinical outcomes.
Source boundary and editorial firewall
The public company link leads directly to Withings' own source. Candidate agreements, identifiers and commercial terms remain internal unless a separate promotion is verified. Supplier data cannot change evidence labels, profile order, safety language or comparative judgement. The company profile remains an editorial record grounded in its cited sources.
Safety, privacy and responsible use
Readers should use the instructions and intended-use boundary for the exact model. Unexpected or concerning measurements should be confirmed through appropriate professional assessment rather than treated as a stand-alone conclusion. Wearable and connected-device use also creates account, cloud, retention, export, deletion and third-party integration questions. Those privacy and security terms can change by product, app version and territory and require separate review before Metatron Health enables data integrations or practitioner workflows.
Open verification work
Open work includes legal-entity and seller mapping by region; batch and model identifiers; independent validation for current models and firmware; performance across diverse populations and activities; warranty and returns; software support duration; data-controller roles; security update policy; product recalls; sustainability evidence; and source-update cadence. Unknown remains a first-class status. This profile neither endorses the company nor ranks it above alternatives.
Machine-readable reviewed statements
CLM-WITHINGS-COMPANY-001
Withings presents a connected ecosystem spanning consumer devices, software and professional health solutions, with a company history beginning in 2008.
Evidence class: company claim
Sources: SRC-WITHINGS-COMPANY-ABOUT-2026
CLM-WITHINGS-HR-002
In a small free-living study, ScanWatch heart-rate error varied by activity; the authors considered it appropriate for general consumer use but not for settings requiring greater measurement accuracy.
Evidence class: clinical validation study
Sources: SRC-WITHINGS-HR-VALIDATION-2022
CLM-WITHINGS-STEPS-003
A study of the older Withings Activite reported underestimation of absolute step counts despite correlation with comparison monitors.
Evidence class: device validation study
Sources: SRC-WITHINGS-STEPS-VALIDATION-2020
Sources and governing contracts
- SRC-WITHINGS-HR-VALIDATION-2022 — JMIR Formative Research, Measurement of Heart Rate Using the Withings ScanWatch Device During Free-living Activities: Validation Study. Role: independent_research. Small independent academic study with public grant funding and no declared manufacturer funding; narrow sample and activity coverage. Open source
- SRC-WITHINGS-STEPS-VALIDATION-2020 — IEEE Engineering in Medicine and Biology Society conference proceedings, Step Count Standardization: Validation of Step Counts from the Withings Activite using PiezoRxD and wGT3X-BT. Role: independent_research. Independent academic comparison of an older model; incomplete accessible funding disclosure and no transfer to current devices. Open source
- SRC-WITHINGS-COMPANY-ABOUT-2026 — Withings, About Us. Role: company_primary. Company-authored source used only for identity, history and the company's description of its own ecosystem. Open source
Reviewed: 2026-08-30 · Version: 2026.08.30.immutable.css-field.20260830T151157551572Z
Continue your journey
Turn this article into a responsible next step.
Compare the wider evidence, check safety boundaries and only then explore access.